Ribonuclease and Thiazolidinedione Compounds and their Use in Methods to Treat Cancer
The present invention relates to methods and kits for the treatment of cancer. A novel drug combination comprising a ribonuclease compound and a thiazolidinedione compound has been identified as producing a synergistic cytotoxicity effect in cancer cells. Methods and kits pertaining to the co-administration of these compounds are discussed herein.
Attached files:Patents:WO 2,009,088,992
Inventor(s):
RAMOS-NINO MARIA E [US]; LITTENBERG BENJAMIN [US]
Type of Offer:
Licensing
« More Medical Patents